Paxman AB (publ) (STO:PAX)

Sweden flag Sweden · Delayed Price · Currency is SEK
79.80
-2.00 (-2.44%)
Aug 1, 2025, 5:24 PM CET
-2.44%
Market Cap1.90B
Revenue (ttm)272.09M
Net Income (ttm)21.58M
Shares Out23.27M
EPS (ttm)1.12
PE Ratio72.84
Forward PE44.10
Dividendn/a
Ex-Dividend Daten/a
Volume9,014
Average Volume27,498
Open80.80
Previous Close81.80
Day's Range79.80 - 80.80
52-Week Range48.80 - 85.80
Beta0.36
RSI47.13
Earnings DateAug 20, 2025

About United States Steel

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1... [Read more]

Sector Healthcare
Founded 1996
Employees 105
Stock Exchange Nasdaq Stockholm
Ticker Symbol PAX
Full Company Profile

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.

Financial Statements

News

There is no news available yet.